Clorox Co. (CLX) Tops Q2 EPS by 12c, Tightens FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
Goldman Sachs Not Convinced Clorox (CLX) Q2 'Beat' was Real
February 5, 2013 11:05 AM ESTGoldman Sachs bumped estimates and its price target on Clorox (NYSE: CLX) higher following Q2 results which easily beat the Street, although the firm is questioned the quality of the beat.
Goldman said while the headline beat was impressive it was almost entity... More



